Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chang

Showing results (191-200 of 5,345) with videos related to

Pageof 535
Sort By:
The Journal of Urology|February 18, 2017
Re: Benefits of Adjuvant Chemotherapy for Bladder CancerSam S Chang
The Journal of Urology|February 18, 2017
Re: Long-Term Outcome of Patients with Frequently Recurrent Non-Muscle-Invasive Bladder Carcinoma Treated with One Perioperative plus Four Weekly Instillations of Mitomycin C followed by Monthly bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 StudySam S Chang
The Journal of Urology|September 19, 2019
Re: Cost-Effectiveness of Pembrolizumab in Second-Line Advanced Bladder CancerSam S Chang
Urology|January 7, 2004
Exploring the effects of luteinizing hormone-releasing hormone agonist therapy on bone health: implications in the management of prostate cancerSam S Chang
The New England Journal of Medicine|June 12, 1975
Letter: What is the determinant for susceptibility to infectious mononucleosis?R S Chang
JAMA|October 5, 1984
Red cell morphology as a diagnostic aid in hematuriaB S Chang
Hawaii Dental Journal|May 1, 1995
Distinguished Service Award: Dr Mark TajimaJ S Chang
The Journal of Urology|November 18, 2017
Re: Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer ClinicSam S Chang
The Journal of Urology|December 23, 2018
Re: Sustained-Release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical StudySam S Chang
The Journal of Urology|November 12, 2019
Re: A Multifactorial Model of T Cell Expansion and Durable Clinical Benefit in Response to a PD-L1 InhibitorSam S Chang
Pageof 535

Showing results (191-200 of 5,345) with videos related to

Sort By:
Pageof 535
The Journal of Urology|February 18, 2017
Re: Benefits of Adjuvant Chemotherapy for Bladder CancerSam S Chang
The Journal of Urology|February 18, 2017
Re: Long-Term Outcome of Patients with Frequently Recurrent Non-Muscle-Invasive Bladder Carcinoma Treated with One Perioperative plus Four Weekly Instillations of Mitomycin C followed by Monthly bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 StudySam S Chang
The Journal of Urology|September 19, 2019
Re: Cost-Effectiveness of Pembrolizumab in Second-Line Advanced Bladder CancerSam S Chang
Urology|January 7, 2004
Exploring the effects of luteinizing hormone-releasing hormone agonist therapy on bone health: implications in the management of prostate cancerSam S Chang
The New England Journal of Medicine|June 12, 1975
Letter: What is the determinant for susceptibility to infectious mononucleosis?R S Chang
JAMA|October 5, 1984
Red cell morphology as a diagnostic aid in hematuriaB S Chang
Hawaii Dental Journal|May 1, 1995
Distinguished Service Award: Dr Mark TajimaJ S Chang
The Journal of Urology|November 18, 2017
Re: Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer ClinicSam S Chang
The Journal of Urology|December 23, 2018
Re: Sustained-Release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical StudySam S Chang
The Journal of Urology|November 12, 2019
Re: A Multifactorial Model of T Cell Expansion and Durable Clinical Benefit in Response to a PD-L1 InhibitorSam S Chang
Pageof 535